Position in TAK
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$3,058,059
+$558,063 QoQ
Shares Held
165,122
+3.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.94%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Carrera Capital Advisors holds $3,058,059 across 1 Drug Manufacturers - Specialty & Generic name. TAK ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
165,122 | $3,058,059 |
All Filings in TAK
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,058,059 | 165,122 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,499,996 | 160,359 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $2,204,754 | 150,598 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $2,151,181 | 139,145 | Shares | Sole | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||